Literature DB >> 27199614

Multi-parametric MRI Assessment of Tumor Response to High-Intensity Focused Ultrasound in a Rat Glioma Model.

Yi Zhang1, Dong-Hoon Lee1, Kai Zhang1, Antonella Mangraviti2, Chen Yang1, Hye-Young Heo1, Betty Tyler2, Ari Partanen3, Keyvan Farahani4, Paul Bottomley1, Peter van Zijl5, Jinyuan Zhou5.   

Abstract

Entities:  

Year:  2015        PMID： 27199614      PMCID： PMC4869733     

Source DB:  PubMed          Journal:  Proc Int Soc Magn Reson Med Sci Meet Exhib Int Soc Magn Reson Med Sci Meet Exhib        ISSN： 1524-6965


× No keyword cloud information.
  5 in total

1.  In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma.

Authors:  Koji Sagiyama; Tomoyuki Mashimo; Osamu Togao; Vamsidhara Vemireddy; Kimmo J Hatanpaa; Elizabeth A Maher; Bruce E Mickey; Edward Pan; A Dean Sherry; Robert M Bachoo; Masaya Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

Review 2.  High-intensity focused ultrasound in the treatment of solid tumours.

Authors:  James E Kennedy
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

3.  Amide proton transfer imaging of high intensity focused ultrasound-treated tumor tissue.

Authors:  Stefanie J C G Hectors; Igor Jacobs; Gustav J Strijkers; Klaas Nicolay
Journal:  Magn Reson Med       Date:  2013-10-23       Impact factor: 4.668

4.  A simple model for understanding the origin of the amide proton transfer MRI signal in tissue.

Authors:  Jinyuan Zhou; Kun Yan; He Zhu
Journal:  Appl Magn Reson       Date:  2012-04       Impact factor: 0.831

5.  Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides.

Authors:  Jinyuan Zhou; Erik Tryggestad; Zhibo Wen; Bachchu Lal; Tingting Zhou; Rachel Grossman; Silun Wang; Kun Yan; De-Xue Fu; Eric Ford; Betty Tyler; Jaishri Blakeley; John Laterra; Peter C M van Zijl
Journal:  Nat Med       Date:  2010-12-19       Impact factor: 53.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.